Recalls / Active ingredient / Nilotinib
Nilotinib
2 FDA drug recalls involving the active ingredient “Nilotinib”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2026-02-18 | Class III | Nilotinib Capsules, 200 mg per capsule, packaged in cartons, Rx only, Manufactured for: Cipla USA, Inc., 10 In | Cipla USA, Inc. |
| 2026-02-18 | Class III | Nilotinib Capsules, 150 mg per capsule, packaged in cartons, Rx only, Manufactured by: Cipla Ltd., Verna, Goa, | Cipla USA, Inc. |